Reasonable option of management approaches for recurrent liver cancer        LAU Wan-yee, LAI Chun-hung, LAU Hiu-yan. Faculty of Medicine, the Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Corresponding author：LAU Wan-yee, E-mail：josephlau@cuhk.edu.hk
Abstract    Recurrence of liver cancer has become the main factor influencing long-term survival of patients performed curative therapy, which is the main reason for postoperative death because of the shortening of survival. Recurrent disease can result from intrahepatic dissemination of a primary tumor (true recurrence) or from de novo development of a new tumor. The principle that determines the choice of therapy for recurrent  liver cancer is the same as that for primary tumor. An aggressive approach to recurrent liver cancer in selected patients is recommended, and a multi-modality approach can prolong survival and improve quality of life of patients. However, the best treatment of recurrent liver cancer remains investigated poorly.